202 related articles for article (PubMed ID: 38566223)
61. Characteristics and Clinical Implications of the Nasal Microbiota in Extranodal NK/T-Cell Lymphoma, Nasal Type.
Shi Z; Li X; Wang X; Zhang L; Li L; Fu X; Sun Z; Li Z; Zhang X; Zhang M
Front Cell Infect Microbiol; 2021; 11():686595. PubMed ID: 34568086
[TBL] [Abstract][Full Text] [Related]
62. Prognostic factors and treatment outcomes for patients with stage II extranodal nasal-type natural killer/T-cell lymphoma of the upper aerodigestive tract.
Fang H; Jin J; Wang WH; Wang SL; Zhou LQ; Li YX
Leuk Lymphoma; 2014 Aug; 55(8):1832-7. PubMed ID: 24144309
[TBL] [Abstract][Full Text] [Related]
63. Quantitative proteomics of CSF reveals potential predicted biomarkers for extranodal NK-/T-cell lymphoma of nasal-type with ethmoidal sinus metastasis.
Gong Y; Pu W; Jin H; Yang P; Zeng H; Wang Y; Pang F; Ma X
Life Sci; 2018 Apr; 198():94-98. PubMed ID: 29496492
[TBL] [Abstract][Full Text] [Related]
64. Resveratrol activates DNA damage response through inhibition of polo-like kinase 1 (PLK1) in natural killer/T cell lymphoma.
Sui X; Zhang C; Jiang Y; Zhou J; Xu C; Tang F; Chen B; Xu H; Wang S; Wang X
Ann Transl Med; 2020 Jun; 8(11):688. PubMed ID: 32617308
[TBL] [Abstract][Full Text] [Related]
65. Expression and significance of Ku80 and PDGFR-α in nasal NK/T-cell lymphoma.
Li J; Chen P; Liu W; Xia Z; Shi F; Zhong M
Pathol Res Pract; 2016 Mar; 212(3):204-9. PubMed ID: 26778387
[TBL] [Abstract][Full Text] [Related]
66. Molecular underpinning of extranodal NK/T-cell lymphoma.
Huang Y; de Leval L; Gaulard P
Best Pract Res Clin Haematol; 2013 Mar; 26(1):57-74. PubMed ID: 23768641
[TBL] [Abstract][Full Text] [Related]
67. Artificial intelligence for diagnosis and prognosis prediction of natural killer/T cell lymphoma using magnetic resonance imaging.
Zhang Y; Deng Y; Zou Q; Jing B; Cai P; Tian X; Yang Y; Li B; Liu F; Li Z; Liu Z; Feng S; Peng T; Dong Y; Wang X; Ruan G; He Y; Cui C; Li J; Luo X; Huang H; Chen H; Li S; Sun Y; Xie C; Wang L; Li C; Cai Q
Cell Rep Med; 2024 May; 5(5):101551. PubMed ID: 38697104
[TBL] [Abstract][Full Text] [Related]
68. Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America.
Montes-Mojarro IA; Chen BJ; Ramirez-Ibarguen AF; Quezada-Fiallos CM; Pérez-Báez WB; Dueñas D; Casavilca-Zambrano S; Ortiz-Mayor M; Rojas-Bilbao E; García-Rivello H; Metrebian MF; Narbaitz M; Barrionuevo C; Lome-Maldonado C; Bonzheim I; Fend F; Steinhilber J; Quintanilla-Martinez L
Mod Pathol; 2020 May; 33(5):781-791. PubMed ID: 31822801
[TBL] [Abstract][Full Text] [Related]
69. Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
Dufva O; Kankainen M; Kelkka T; Sekiguchi N; Awad SA; Eldfors S; Yadav B; Kuusanmäki H; Malani D; Andersson EI; Pietarinen P; Saikko L; Kovanen PE; Ojala T; Lee DA; Loughran TP; Nakazawa H; Suzumiya J; Suzuki R; Ko YH; Kim WS; Chuang SS; Aittokallio T; Chan WC; Ohshima K; Ishida F; Mustjoki S
Nat Commun; 2018 Apr; 9(1):1567. PubMed ID: 29674644
[TBL] [Abstract][Full Text] [Related]
70. Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway.
Sui X; Zhang C; Zhou J; Cao S; Xu C; Tang F; Zhi X; Chen B; Wang S; Yin L
J Exp Clin Cancer Res; 2017 Sep; 36(1):133. PubMed ID: 28950914
[TBL] [Abstract][Full Text] [Related]
71. Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A/B loss, and TP53 mutations: A multi-institutional study.
Streich L; Sukhanova M; Lu X; Chen YH; Venkataraman G; Mathews S; Zhang S; Kelemen K; Segal J; Gao J; Gordon L; Chen Q; Behdad A
Genes Chromosomes Cancer; 2020 Aug; 59(8):484-494. PubMed ID: 32277542
[TBL] [Abstract][Full Text] [Related]
72. Overexpression of S100A9 in tumor stroma contribute to immune evasion of NK/T cell lymphoma and predict poor response rate.
Zhou Z; Chen X; Li Z; Wang X; Zhang M
Sci Rep; 2021 May; 11(1):11220. PubMed ID: 34045609
[TBL] [Abstract][Full Text] [Related]
73. p63 and p53 expression in extranodal NK/T cell lymphoma, nasal type.
Ye Z; Cao Q; Niu G; Liang Y; Liu Y; Jiang L; Yu X; Han A
J Clin Pathol; 2013 Aug; 66(8):676-80. PubMed ID: 23626008
[TBL] [Abstract][Full Text] [Related]
74. A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.
Lim JQ; Huang D; Chan JY; Laurensia Y; Wong EKY; Cheah DMZ; Chia BKH; Chuang WY; Kuo MC; Su YJ; Cai QQ; Feng Y; Rao H; Feng LN; Wei PP; Chen JR; Han BW; Lin GW; Cai J; Fang Y; Tan J; Hong H; Liu Y; Zhang F; Li W; Poon MLM; Ng SB; Jeyasekharan A; Ha JCH; Khoo LP; Chin ST; Pang WL; Kee R; Cheng CL; Grigoropoulos NF; Tang T; Tao M; Farid M; Puan KJ; Xiong J; Zhao WL; Khor CC; Hwang W; Kim WS; Campo E; Tan P; Teh BT; Chng WJ; Rötzschke O; Tousseyn T; Huang HQ; Rozen S; Lim ST; Shih LY; Bei JX; Ong CK
Am J Hematol; 2022 Sep; 97(9):1159-1169. PubMed ID: 35726449
[TBL] [Abstract][Full Text] [Related]
75. Towards Next Generation Biomarkers in Natural Killer/T-Cell Lymphoma.
Chan JY; Lim JQ; Ong CK
Life (Basel); 2021 Aug; 11(8):. PubMed ID: 34440582
[TBL] [Abstract][Full Text] [Related]
76. Abnormal pretreatment coagulation factor levels correlate with poor prognosis in patients with early-stage extranodal nasal-type natural/killer T cell lymphoma.
Chai Y; Qi F; Chen B; Gui L; Yang J; Qi S; Song Y; Li Y; Wei Y; Dong M
Ann Hematol; 2020 Jun; 99(6):1303-1309. PubMed ID: 32333152
[TBL] [Abstract][Full Text] [Related]
77. Activated janus kinase 3 expression not by activating mutations identified in natural killer/T-cell lymphoma.
Guo Y; Arakawa F; Miyoshi H; Niino D; Kawano R; Ohshima K
Pathol Int; 2014 Jun; 64(6):263-6. PubMed ID: 24965108
[TBL] [Abstract][Full Text] [Related]
78. The impact of the omission or inadequate dosing of radiotherapy in extranodal natural killer T-cell lymphoma, nasal type, in the United States.
Vargo JA; Patel A; Glaser SM; Balasubramani GK; Farah RJ; Marks SM; Beriwal S
Cancer; 2017 Aug; 123(16):3176-3185. PubMed ID: 28380259
[TBL] [Abstract][Full Text] [Related]
79. Oncogenic Network and Hub Genes for Natural Killer/T-Cell Lymphoma Utilizing WGCNA.
Liu H; Liu M; You H; Li X; Li X
Front Oncol; 2020; 10():223. PubMed ID: 32195177
[TBL] [Abstract][Full Text] [Related]
80. GNAQ T96S mutation abrogates the ability of wild-type GNAQ to induce apoptosis by phosphorylating annexin A2 in natural killer/T cell lymphoma.
Zhao W; Zhang M; Wang G; Liu E; Jiang G; Zhang Y; Zhang D; Jian X; Zhao H; Zhang C; Li W
Cancer Sci; 2022 Jul; 113(7):2288-2296. PubMed ID: 35293080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
